Eledon Pharmaceuticals, Inc. Net Income
Eledon Pharmaceuticals, Inc. (ELDN) reported Net Income of -$31.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-13
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$31.63M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$39.02M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$10.45M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$17.46M, a 122.68% decline year-over-year.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2022 was -$87.97M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2021 was -$34.51M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2020 was -$22.81M.
- Eledon Pharmaceuticals, Inc. net income (loss) attributable to parent for fiscal 2019 was -$16.01M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$31.63M 10-Q · filed 2026-08-13 | -$70.66M 10-Q · filed 2026-08-13 | -$81.10M derived: sum of 3 quarters · filed 2026-08-13 | -$98.56M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$39.02M 10-Q · filed 2026-08-13 | -$49.47M derived: sum of 2 quarters · filed 2026-08-13 | -$66.93M derived: sum of 3 quarters · filed 2026-08-13 | -$78.15M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$10.45M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30 | -$27.91M derived: sum of 2 quarters · filed 2026-04-30 | -$39.12M derived: sum of 3 quarters · filed 2026-08-13 | -$45.62M DEF 14A · filed 2026-04-30 | ||||
| 2025-09-30 | -$17.46M 10-Q · filed 2025-11-14 | -$28.68M derived: sum of 2 quarters · filed 2026-08-13 | -$35.17M 10-Q · filed 2025-11-14 | -$79.79M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$11.22M 10-Q · filed 2026-08-13 | -$17.71M 10-Q · filed 2026-08-13 | -$62.33M derived: sum of 3 quarters · filed 2026-08-13 | $14.64M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$6.50M 10-Q · filed 2026-08-13 | -$51.11M derived: sum of 2 quarters · filed 2026-08-13 | $25.86M derived: sum of 3 quarters · filed 2026-08-13 | -$19.05M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2024-12-31 | -$44.62M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30 | $32.35M derived: sum of 2 quarters · filed 2026-04-30 | -$12.55M derived: sum of 3 quarters · filed 2026-04-30 | -$36.18M DEF 14A · filed 2026-04-30 | ||||
| 2024-09-30 | $76.97M 10-Q · filed 2025-11-14 | $32.06M derived: sum of 2 quarters · filed 2025-11-14 | $8.43M 10-Q · filed 2025-11-14 | -$21.67M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-06-30 | -$44.91M 10-Q · filed 2025-11-14 | -$68.54M 10-Q · filed 2025-08-14 | -$98.64M derived: sum of 3 quarters · filed 2026-04-30 | -$108.54M derived: sum of 4 quarters · filed 2026-04-30 | ||||
| 2024-03-31 | -$23.63M 10-Q · filed 2025-11-14 | -$10.29M 10-Q · filed 2024-05-15 | -$53.73M derived: sum of 2 quarters · filed 2026-04-30 | -$63.64M derived: sum of 3 quarters · filed 2026-04-30 | -$129.40M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2023-12-31 | -$30.10M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30 | -$40.01M derived: sum of 2 quarters · filed 2026-04-30 | -$105.77M derived: sum of 3 quarters · filed 2026-04-30 | -$116.54M DEF 14A · filed 2026-04-30 | -$40.33M 10-K · filed 2024-03-28 | |||
| 2023-09-30 | -$9.91M 10-Q · filed 2024-11-12 | -$10.35M 10-Q · filed 2023-11-09 | -$75.67M derived: sum of 2 quarters · filed 2024-11-12 | -$86.44M 10-Q · filed 2024-11-12 | -$30.70M 10-Q · filed 2023-11-09 | -$144.82M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$65.76M 10-Q · filed 2024-11-12 | -$9.58M 10-Q · filed 2023-08-10 | -$76.53M 10-K/A · filed 2024-08-19 | -$20.35M 10-Q · filed 2023-08-10 | -$134.92M derived: sum of 3 quarters · filed 2024-11-12 | -$145.39M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-03-31 | -$10.77M 10-Q · filed 2024-11-12 | -$69.16M derived: sum of 2 quarters · filed 2024-11-12 | -$79.63M derived: sum of 3 quarters · filed 2024-11-12 | -$88.87M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2022-12-31 | -$58.38M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-19 | -$68.86M derived: sum of 2 quarters · filed 2024-08-19 | -$78.10M derived: sum of 3 quarters · filed 2024-08-19 | -$87.97M 10-K/A · filed 2024-08-19 | ||||
| 2022-09-30 | -$10.47M 10-Q · filed 2023-11-09 | -$19.72M derived: sum of 2 quarters · filed 2023-11-09 | -$29.58M 10-Q · filed 2023-11-09 | -$38.39M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$9.25M 10-Q · filed 2023-11-09 | -$19.11M 10-Q · filed 2023-08-10 | -$27.92M derived: sum of 3 quarters · filed 2023-11-09 | -$37.73M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-03-31 | -$9.86M 10-Q · filed 2023-11-09 | -$18.67M derived: sum of 2 quarters · filed 2023-11-09 | -$28.49M derived: sum of 3 quarters · filed 2023-11-09 | -$35.87M derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2021-12-31 | -$8.81M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$18.62M derived: sum of 2 quarters · filed 2023-03-30 | -$26.01M derived: sum of 3 quarters · filed 2023-03-30 | -$34.51M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | -$9.82M 10-Q · filed 2022-11-14 | -$17.20M derived: sum of 2 quarters · filed 2022-11-14 | -$25.70M 10-Q · filed 2022-11-14 | -$31.60M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$7.38M 10-Q · filed 2022-08-11 | -$15.88M 10-Q · filed 2022-08-11 | -$21.79M derived: sum of 3 quarters · filed 2022-08-11 | -$27.93M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$8.50M 10-Q · filed 2022-05-12 | -$14.40M derived: sum of 2 quarters · filed 2022-05-12 | -$20.55M derived: sum of 3 quarters · filed 2022-05-12 | -$23.13M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$12.05M derived: sum of 2 quarters · filed 2022-03-24 | -$14.63M derived: sum of 3 quarters · filed 2022-03-24 | -$22.81M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | -$6.14M 10-Q · filed 2021-11-12 | -$8.73M derived: sum of 2 quarters · filed 2021-11-12 | -$16.91M 10-Q · filed 2021-11-12 | -$21.05M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$2.59M 10-Q · filed 2021-08-12 | -$10.76M 10-Q · filed 2021-08-12 | -$14.91M derived: sum of 3 quarters · filed 2021-08-12 | -$17.80M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$8.18M 10-Q · filed 2021-05-14 | -$12.32M derived: sum of 2 quarters · filed 2021-05-14 | -$15.21M derived: sum of 3 quarters · filed 2021-05-14 | -$19.31M derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$4.14M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$7.04M derived: sum of 2 quarters · filed 2021-03-31 | -$11.13M derived: sum of 3 quarters · filed 2021-03-31 | -$16.01M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$2.89M 10-Q · filed 2020-11-16 | -$6.99M derived: sum of 2 quarters · filed 2020-11-16 | -$11.87M 10-Q · filed 2020-11-16 | -$16.44M derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | -$4.09M 10-Q · filed 2020-08-14 | -$8.97M 10-Q · filed 2020-08-14 | -$13.55M derived: sum of 3 quarters · filed 2020-08-14 | -$17.04M derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | -$4.88M 10-Q · filed 2020-05-15 | -$9.46M derived: sum of 2 quarters · filed 2020-05-15 | -$12.95M derived: sum of 3 quarters · filed 2020-05-15 | -$16.14M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | -$4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$8.07M derived: sum of 2 quarters · filed 2020-03-17 | -$11.26M derived: sum of 3 quarters · filed 2020-03-17 | -$14.06M 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | -$3.50M 10-Q · filed 2019-11-13 | -$6.68M derived: sum of 2 quarters · filed 2019-11-13 | -$9.49M 10-Q · filed 2019-11-13 | -$11.60M derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | -$3.19M 10-Q · filed 2019-08-13 | -$6.00M 10-Q · filed 2019-08-13 | -$8.11M derived: sum of 3 quarters · filed 2019-08-13 | -$11.07M derived: sum of 4 quarters · filed 2019-08-13 | ||||
| 2018-03-31 | -$2.81M 10-Q · filed 2019-05-14 | -$4.92M derived: sum of 2 quarters · filed 2019-05-14 | -$7.89M derived: sum of 3 quarters · filed 2019-05-14 | -$14.55M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | -$5.08M derived: sum of 2 quarters · filed 2019-03-28 | -$11.74M derived: sum of 3 quarters · filed 2019-03-28 | -$13.12M 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$2.97M 10-Q · filed 2018-11-13 | -$9.63M derived: sum of 2 quarters · filed 2018-11-13 | -$11.01M 10-Q · filed 2018-11-13 | -$14.74M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | -$6.66M 10-Q · filed 2018-08-07 | -$8.04M 10-Q · filed 2018-08-07 | -$11.77M derived: sum of 3 quarters · filed 2018-08-07 | -$13.81M derived: sum of 4 quarters · filed 2018-08-07 | ||||
| 2017-03-31 | -$1.37M 10-Q · filed 2018-05-11 | -$3.87M 10-Q · filed 2017-05-03 | -$5.11M derived: sum of 2 quarters · filed 2018-05-11 | -$7.15M derived: sum of 3 quarters · filed 2018-05-11 | -$8.15M derived: sum of 4 quarters · filed 2018-05-11 | |||
| 2016-12-31 | -$3.74M 10-K · filed 2017-03-03 | -$5.77M derived: sum of 2 quarters · filed 2017-11-08 | -$6.77M derived: sum of 3 quarters · filed 2017-11-08 | -$5.66M 10-K · filed 2018-04-02 | -$37.96M 10-K · filed 2017-03-03 | |||
| 2016-09-30 | -$2.04M 10-Q · filed 2017-11-08 | -$9.27M 10-Q · filed 2016-11-03 | -$3.04M derived: sum of 2 quarters · filed 2017-11-08 | -$4.14M 10-Q · filed 2017-11-08 | -$34.22M 10-Q · filed 2016-11-03 | -$25.48M derived: sum of 4 quarters · filed 2017-11-08 | ||
| 2016-06-30 | -$1.00M 10-Q · filed 2017-08-09 | -$13.53M 10-Q · filed 2016-08-04 | -$2.10M 10-Q · filed 2017-08-09 | -$24.95M 10-Q · filed 2016-08-04 | -$23.45M derived: sum of 3 quarters · filed 2017-08-09 | -$35.30M derived: sum of 4 quarters · filed 2017-08-09 | ||
| 2016-03-31 | -$11.43M 10-Q · filed 2017-05-03 | -$22.44M derived: sum of 2 quarters · filed 2017-05-03 | -$34.30M derived: sum of 3 quarters · filed 2017-05-03 | -$43.25M derived: sum of 4 quarters · filed 2017-05-03 | ||||
| 2015-12-31 | -$11.02M 10-K · filed 2017-03-03 | -$22.87M derived: sum of 2 quarters · filed 2017-03-03 | -$31.83M derived: sum of 3 quarters · filed 2017-03-03 | -$45.09M 10-K · filed 2017-03-03 | ||||
| 2015-09-30 | -$11.85M 10-K · filed 2017-03-03 | -$20.81M derived: sum of 2 quarters · filed 2017-03-03 | -$34.07M 10-Q · filed 2016-11-03 | -$40.28M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-06-30 | -$8.96M 10-K · filed 2017-03-03 | -$22.22M 10-Q · filed 2016-08-04 | -$28.43M derived: sum of 3 quarters · filed 2017-03-03 | -$34.81M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2015-03-31 | -$13.26M 10-K · filed 2017-03-03 | -$19.47M derived: sum of 2 quarters · filed 2017-03-03 | -$25.86M derived: sum of 3 quarters · filed 2017-03-03 | -$31.71M derived: sum of 4 quarters · filed 2017-03-03 | ||||
| 2014-12-31 | -$6.21M 10-K · filed 2016-03-10 | -$12.60M derived: sum of 2 quarters · filed 2016-03-10 | -$18.45M derived: sum of 3 quarters · filed 2016-03-10 | -$23.30M 10-K · filed 2017-03-03 | ||||
| 2014-09-30 | -$6.39M 10-K · filed 2016-03-10 | -$12.24M derived: sum of 2 quarters · filed 2016-03-10 | -$17.09M 10-Q · filed 2015-11-10 | -$22.61M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-06-30 | -$5.85M 10-K · filed 2016-03-10 | -$10.70M 10-Q · filed 2015-08-12 | -$16.22M derived: sum of 3 quarters · filed 2016-03-10 | -$19.59M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2014-03-31 | -$4.85M 10-K · filed 2016-03-10 | -$10.37M derived: sum of 2 quarters · filed 2016-03-10 | -$13.74M derived: sum of 3 quarters · filed 2016-03-10 | -$18.18M derived: sum of 4 quarters · filed 2016-03-10 | ||||
| 2013-12-31 | -$5.53M 10-K · filed 2015-03-26 | -$8.89M derived: sum of 2 quarters · filed 2015-03-26 | -$13.34M derived: sum of 3 quarters · filed 2015-03-26 | -$15.72M 10-K · filed 2016-03-10 | ||||
| 2013-09-30 | -$3.37M 10-K · filed 2015-03-26 | -$7.81M derived: sum of 2 quarters · filed 2015-03-26 | -$10.20M 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | -$4.45M 10-K · filed 2015-03-26 | -$6.83M derived: sum of 2 quarters · filed 2015-03-26 | ||||||
| 2013-03-31 | -$2.39M 10-K · filed 2015-03-26 | |||||||
| 2012-12-31 | -$9.65M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |